Incheon Yeonsu-gu Launches Resident Petition Campaign to Attract 'K-Bio Lab Hub' to Songdo

Gonam-seok, head of Yeonsu District Office (left), is promoting participation in the resident signature campaign to attract the 'K-Bio Lab Hub' at Songdo Technopark Station.
[Photo by Yeonsu District, Incheon]

[Asia Economy Reporter Park Hyesook] Yeonsu-gu, Incheon, has launched a large-scale signature campaign targeting residents to attract the government's national representative bio startup company support project, the 'K-Bio Lab Hub,' to Incheon City.

The K-Bio Lab Hub is a project that benchmarks 'LabCentral,' a bio startup support institution in Boston, USA, which produced the famous pharmaceutical company 'Moderna,' to build a platform where everything from new drug development to prototype production is possible in one space.

Currently, the Ministry of SMEs and Startups is recruiting local governments to promote the establishment of the K-Bio Lab Hub until the 14th of next month. Incheon City, where Samsung Biologics and Celltrion are located in Songdo International City, Yeonsu-gu, has submitted a letter of intent to attract the project.

Accordingly, on the 28th, Yeonsu-gu set up a signature booth at Songdo Technopark Station and held a promotional event encouraging residents to participate in the signature campaign and praying for the attraction.

The district has placed signature books at each dong administrative welfare center and apartment elevators to encourage residents to participate, and has also requested cooperation from the Songdo International City apartment residents' representative meetings so that 'local residents' enthusiasm for attraction' can be reflected in the evaluation process.

The district plans to actively carry out the signature campaign centered on administrative welfare centers and apartment residents until the 4th of next month and submit the signature books containing the local residents' will to attract the project to Incheon City.

Incheon is home to anchor companies of Korea's bio industry, such as Samsung Biologics, which is investing 1.7 trillion won in its 4th plant, and Celltrion, which is investing 500 billion won in its 3rd plant.

In particular, Incheon City expects that more bio companies will be born in the region through the attraction of the K-Bio Lab Hub, just as Celltrion, which started in a barren environment in 2002, grew to announce a 25 trillion won investment in 2019.

Gonam-seok, mayor of Yeonsu-gu, said, "The establishment of the K-Bio Lab Hub will revitalize the local economy, solve job problems, and furthermore, provide an opportunity to actively respond to future infectious diseases," urging active participation from residents.

This content was produced with the assistance of AI translation services.